Dezin Counsulting Private Limited

New Business & New Therapy Launch in Pharma Market

New Business & New Therapy Launch in Pharma Market

We help the new business launch as well as new therapy segment launch from the basic market research up to making it successful in market. The activities include providing basic reports about market or therapy segments, External data, Product selection, Regulatory requirements, Contract manufacturing (If needed), recruitments/ HR Services, setting up distribution network, planning & preparing of promotion material, launch strategy, target customer lists, Promotional plan and payment collection system.

Entering into new business or new therapy segment need expertise of various area of pharma business in India. We have highly experienced and result oriented team of professionals to assist you at every step. Our team insure that your investment is in right place and you gets best ROI on your investments.

Entering into new business or new therapy segment need expertise of various area of pharma business in India. We have highly experienced and result oriented team of professionals to assist you at every step. Our team insure that your investment is in right place and you gets best ROI on your investments.

In current pharma market scenario certain things which are emerging as very critical are – Quality of Products, Efficiency of team and Cost effectiveness of operation. In this environment, it become important decision that where to have fixed cost and where we should outsource services.

We at Dezin have very flexible approach to assist you whichever part of operation you want to outsource and where you want consulting support and which area you want to operate yourself. Dezin is ideal Indian partner for multinational companies (MNCs) operating in India or want to expand here or want to enter Indian pharma market. We are equally good potential partner to Indian companies who want to enter Indian pharma market, expand operations or want to work upon efficiency or cost effectiveness part of operations.

India as home of over 15% of world population has huge growth scope in pharma market. It will not be wrong to say that Indian pharma market is recession free market for at least next three decades. Till now India’s 50% market is dominated by acute segment, but growth in chronic / sub chronic segments are much faster than acute segments. With the changing socio-economic pattern in India, life styles diseases market is all set to grow much faster in coming years. On the other hand India is shifting from non-regulated market to regulated market. These all changes make it as right time to enter, expand in Indian pharma market.